Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities during the specified class period of the upcoming lead plaintiff deadline on June 3, 2025 [1] Group 1: Class Action Details - Investors who purchased Canopy Growth securities between May 30, 2024, and February 6, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3][6] - The lawsuit alleges that Canopy Growth made false and misleading statements regarding its financial health and cost management, which negatively impacted investors when the truth was revealed [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [4] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [4] - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in representing clients [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities between May 30, 2024, and February 6, 2025, of the June 3, 2025, lead plaintiff deadline for a class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Canopy Growth securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by June 3, 2025 [3]. - Investors can join the class action by visiting the provided link or contacting the law firm directly for more information [6]. Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4]. - The firm has secured significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [4]. Group 3: Case Allegations - The lawsuit alleges that Canopy Growth made false and misleading statements regarding the costs associated with the launch of its Claybourne product and the impact on its gross margins [5]. - It is claimed that the company overstated the effectiveness of its cost reduction measures while downplaying financial issues, leading to investor damages when the true information became public [5].

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding significant costs incurred during the production of Claybourne pre-rolled joints and the launch of the Claybourne product in Canada [2]. - It is alleged that these costs, along with indirect costs related to Storz & Bickel vaporizer devices, would significantly harm the Company's gross margins and overall financial results [2]. - The defendants are accused of overstating the effectiveness of Canopy's cost reduction measures and the health of its gross margins while minimizing related issues [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4].

Industry Overview - The cannabis industry is experiencing growth and profitability, with companies reporting positive Q1 2025 earnings despite a challenging market environment [1][2] - There is a notable disconnect between the performance of cannabis stocks and the success of legal operators, leading to speculation about potential investment opportunities [2][3] Company Highlights - **Tilray Brands, Inc.**: Engages in the research, cultivation, processing, and distribution of medical cannabis products. Recently launched a new line of cannabis beverages and gummies [4][6] - **Canopy Growth Corporation**: Focuses on the production and sale of cannabis products for recreational and medical purposes. Scheduled to release Q1 2025 financial results on May 30th [7][8] - **Cronos Group Inc.**: Involved in the cultivation and marketing of cannabis products. Reported Q1 2025 earnings on May 8th [9] Financial Performance - MAPH Enterprises reported a net revenue of $32.3 million in Q1 2025, an increase of $7.0 million from Q1 2024 - Gross profit for MAPH Enterprises reached $13.7 million in Q1 2025, up by $9.3 million from the previous year - Adjusted gross profit was $14.3 million in Q1 2025, reflecting an increase of $9.8 million from Q1 2024 - Net income for MAPH Enterprises was $7.7 million in Q1 2025, which is an increase of $10.2 million compared to Q1 2024 [11]

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding significant costs incurred during the launch of Claybourne pre-rolled joints and the Storz & Bickel vaporizer devices, which adversely affected the company's gross margins and financial results [2]. - It is alleged that the company overstated the effectiveness of its cost reduction measures and misrepresented the health of its gross margins while downplaying related issues [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving in this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Canopy Growth Corporation securities between May 30, 2024, and February 6, 2025, of the upcoming lead plaintiff deadline on June 3, 2025 [1] Group 1: Class Action Details - Investors who purchased Canopy Growth securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6] - The lawsuit alleges that Canopy Growth made false and misleading statements regarding its financial health and cost management, which negatively impacted investors when the truth was revealed [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4] - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements [4]

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding the costs associated with the production of Claybourne pre-rolled joints and Storz & Bickel vaporizer devices, which were likely to adversely affect the company's gross margins and overall financial results [2]. - It is alleged that the defendants overstated the effectiveness of Canopy's cost reduction measures and misrepresented the health of its gross margins while downplaying existing issues [2]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Canopy Growth Corporation regarding a class action lawsuit due to alleged misleading statements and undisclosed costs impacting the company's financial performance [1][2]. Allegations - The complaint alleges that Canopy Growth incurred significant costs related to the production of Claybourne pre-rolled joints during its product launch in Canada [1]. - It is claimed that these costs, along with indirect costs from Storz & Bickel vaporizer devices, negatively affected the company's gross margins and overall financial results [1]. - The defendants are accused of overstating the effectiveness of Canopy's cost reduction measures and the health of its gross margins while downplaying existing issues [1]. - As a result, the public statements made by the defendants are considered materially false and misleading throughout the relevant period [1]. Class Action Details - The class period for the lawsuit is from May 30, 2024, to February 6, 2025, and shareholders are encouraged to register by June 3, 2025, to participate [2]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights who have suffered losses due to deceit, fraud, and illegal business practices [3]. - The firm is committed to ensuring companies engage in responsible business practices and good corporate citizenship [3].

Core Viewpoint - A class action securities lawsuit has been filed against Canopy Growth Corporation, alleging securities fraud that negatively impacted investors between May 30, 2024, and February 6, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Canopy Growth Corporation made false statements regarding the costs associated with the launch of Claybourne pre-rolled joints and the Storz & Bickel vaporizer devices, which were likely to adversely affect the company's gross margins and overall financial results [2]. - It is alleged that the defendants overstated the effectiveness of Canopy's cost reduction measures and the health of its gross margins while downplaying related issues, leading to materially false and misleading public statements [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until June 3, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - A class action lawsuit has been filed against Canopy Growth Corporation for allegedly misleading investors regarding its cost reduction measures and financial performance during a specified period [1][2]. Allegations - The lawsuit claims that Canopy Growth Corporation failed to disclose significant costs associated with the production of Claybourne pre-rolled joints and indirect costs related to Storz & Bickel vaporizer devices, which negatively impacted the company's gross margins and overall financial results [2]. - It is alleged that the company overstated the effectiveness of its cost reduction measures while downplaying issues related to its gross margins [2]. Financial Impact - On February 7, 2025, Canopy announced disappointing financial results attributed to the costs from the Claybourne product launch and increased indirect costs, leading to a 27.24% drop in share price, closing at $2.02 [3]. Class Action Participation - Shareholders may be eligible to participate in the class action against Canopy Growth Corporation, with a deadline for lead plaintiff applications set for June 3, 2025 [4]. Company Background - Robbins LLP is noted as a leader in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [5].